Siegel , Daniel, Christopher Murphy, Kent Wangsness, Allyson Perry, and Ian Smith. “Cost-Benefit Analysis of the Pigmented Lesion Assay When Introduced Into the Visual Assessment / Histopathology Pathway for Lesions Clinically Suspicious for Melanoma”. SKIN The Journal of Cutaneous Medicine 6, no. 2 (March 4, 2022): 109–121. Accessed August 18, 2022. https://jofskin.org/index.php/skin/article/view/1475.